Published in J Clin Pathol on November 01, 1975
Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin. Clin Exp Immunol (1976) 1.45
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
Cancer-associated proteins in effusion fluids. J Clin Pathol (1977) 0.83
Clinicopathological role of tumour index substances in paediatric neoplasia. J Clin Pathol (1976) 0.77
In vitro monocyte maturation in squamous-cell carcinoma of the lung: influence of humoral factors. Br J Cancer (1982) 0.75
A critical comparison of the value of pregnancy-associated alpha2-glycoprotein and carcinoembryonic antigen assays in patients with colorectal cancer. J Clin Pathol (1978) 0.75
The detection and measurement of oncodevelopmental proteins in gynecological malignant disease. Arch Gynecol (1982) 0.75
Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem (1966) 21.70
DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med (1965) 12.88
Foetal antigens and their role in the diagnosis and clinical management of human neoplasms: a review. Br J Cancer (1972) 2.53
Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res (1968) 2.28
Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA (1972) 1.51
Studies on pregnancy-associated globulin. Clin Exp Immunol (1973) 1.50
Inhibition of PHA-induced lymphocyte stimulation by the pregnancy zone protein. FEBS Lett (1973) 1.21
Correlation of preoperative lymphocyte reactivity with the clinical course of cancer patients. Surg Gynecol Obstet (1973) 1.21
Normal and increased alpha-fetoprotein in neoplastic and non-neoplastic liver disease. Lancet (1972) 1.18
Synthesis of a pregnancy-associated alpha-macroglobulin by human leucocytes. Experientia (1975) 1.16
An immunoassay for a pregnancy-associated alpha-macroglobulin using antibody-enzyme conjugates. FEBS Lett (1974) 1.15
The isolation and partial characterisation of a new alpha-macroglobulin from human pregnancy serum. FEBS Lett (1972) 1.13
Transplantation--nature's success. Lancet (1972) 1.11
Variations in the serum concentration of a human pregnancy-associated alpha-macroglobulin during pregnancy and after delivery. J Reprod Fertil (1975) 1.07
Proceedings: Carcinoembryonic antigen. Report of a screening study. Cancer (1974) 1.06
Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet (1975) 1.06
A quantitative study of the pregnancy zone protein in the sera of pregnant and puerperal women. Am J Obstet Gynecol (1974) 1.02
Purification of the "pregnancy zone" protein. Acta Obstet Gynecol Scand (1973) 0.99
Letter: An antigen associated with pregnancy. Lancet (1974) 0.95
Lack of steroid-binding by "pregnancy zone" protein. J Steroid Biochem (1973) 0.85
Cellular immunity to human tumor-associated antigens. A review. Isr J Med Sci (1973) 0.81
Detection of the "pregnancy zone" protein by means of an immunodiffusion method. Acta Obstet Gynecol Scand (1973) 0.78
Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin. Clin Exp Immunol (1976) 1.45
Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobulin. Br J Surg (1976) 1.30
Synthesis of a pregnancy-associated alpha-macroglobulin by human leucocytes. Experientia (1975) 1.16
An immunoassay for a pregnancy-associated alpha-macroglobulin using antibody-enzyme conjugates. FEBS Lett (1974) 1.15
Oestrogen receptors in macrophages. Scand J Immunol (1990) 1.13
Transplantation--nature's success. Lancet (1972) 1.11
Variations in the serum concentration of a human pregnancy-associated alpha-macroglobulin during pregnancy and after delivery. J Reprod Fertil (1975) 1.07
Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet (1975) 1.06
Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines. J Clin Lab Immunol (1987) 1.05
Studies of thyroglobulin autoantibody synthesis using a micro-ELISA assay. Immunol Lett (1982) 1.02
Identification of an immunosuppressive factor in pregnancy serum. Obstet Gynecol (1976) 1.01
Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin. J Clin Lab Immunol (1990) 0.99
Identification of pregnancy-associated alpha-macroglobulin on the surface of peripheral blood leucocyte populations. Clin Exp Immunol (1977) 0.98
A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98
Oestrogen-induced immunoregulation mediated through the thymus. J Clin Lab Immunol (1980) 0.96
Pregnancy-associated beta 1-macroglobulin: detection on the surface of ovarian cancer cell lines. Int J Cancer (1985) 0.94
Are pregnancy-associated serum proteins responsible for the inhibition of lymphocyte transformation by pregnancy serum? Clin Exp Immunol (1980) 0.92
Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA). Eur J Cancer (1979) 0.90
Effects of steroids on the secretion of immunoregulatory factors by thymic epithelial cell cultures. Immunology (1981) 0.90
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
Protein markers in disease (2). Pregnancy-associated alpha2-glycoprotein and cancer. J R Coll Surg Edinb (1978) 0.89
The human bladder carcinoma line T-24 secretes a human B-cell differentiation factor. Immunology (1987) 0.87
The effects of nandrolone, testosterone and their decanoate esters on murine lupus. Clin Exp Immunol (1981) 0.87
Letter: Immunosuppressive effect of pregnancy-associated alpha2-macroglobulin. Lancet (1975) 0.86
Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother (1990) 0.86
Studies on the maternal immune response to placental antigens: absence of a blocking factor from the blood of abortion-prone women. Br J Obstet Gynaecol (1979) 0.86
The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. Br J Cancer (1975) 0.85
Comparison of the effects of human pregnancy serum and anti-inflammatory compounds on the release of lysosomal enzymes from macrophages. Br J Exp Pathol (1977) 0.85
M4HS2, a new human T-cell line for the efficient generation of human T-cell hybrids. J Immunol Methods (1986) 0.85
Immunoneutralisation of gonadotrophin releasing hormone: a potential treatment for oestrogen-dependent breast cancer. Eur J Cancer (1997) 0.84
Screening for metastases in breast cancer: an assessment of biochemical and physical methods. Cancer (1981) 0.84
Immunoscintigraphy of metastases with radiolabelled human antibodies. Br Med J (Clin Res Ed) (1987) 0.84
Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis (1983) 0.83
Effects of adjuvant, dose and carrier pre-sensitisation on the immunisation efficacy of a GnRH analogue. Drug Des Discov (1996) 0.82
T-24.B-cell differentiation factor induces immunoglobulin secretion in human B cells without prior cell replication. Immunology (1987) 0.81
Human T-cell hybrids secreting lymphokines: effect of different parent cell clones of the human T-cell acute lymphoblastoid leukaemia line CCRF-CEM. Scand J Immunol (1986) 0.81
Fertility-disrupting potential of synthetic peptides derived from the beta-subunit of follicle-stimulating hormone. Am J Reprod Immunol (1998) 0.81
The molecular weight of pregnancy-associated alpha2-glycoprotein and its subunits. Int J Biochem (1978) 0.80
Determination of anti-DNA autoantibody levels in mice by enzyme immunoassay. J Clin Lab Immunol (1984) 0.80
Effects of dietary supplementation on autoimmunity in the MRL/lpr mouse: a preliminary investigation. Ann Rheum Dis (1986) 0.80
Cytokines regulate the ability of human LAK-cells to kill human tumour cells in vitro. Br J Cancer (1989) 0.80
A rapid enzyme immunoassay for the detection of IgM rheumatoid factor--a comparison of "sero-negative" and "sero-positive" rheumatoid patients. J Clin Lab Immunol (1986) 0.79
Androgen binding cytosol receptors in the rat thymus: physicochemical properties, specificity and localisation. Thymus (1981) 0.79
Investigation into suitable carrier molecules for use in an anti-gonadotrophin releasing hormone vaccine. Vaccine (1998) 0.79
Rheumatoid factor induction in the mouse: sex differences and the effect of the sex steroids. Immunopharmacology (1990) 0.79
A novel method for boronating antibodies without loss of immunoreactivity, for use in neutron capture therapy. Drug Des Discov (1995) 0.79
Cardiac myofibrillar proteins: biochemical markers to estimate myocardial injury. Mol Cell Biochem (1999) 0.79
Accurate determination of adjuvant-associated protein or peptide by ninhydrin assay. Vaccine (1995) 0.78
A role for amniotic epithelium in control of human parturition. Lancet (1985) 0.78
Studies on the changes in the concentration and total mass of individual serum proteins during late pregnancy. Clin Biochem (1972) 0.78
Generation of human T-cell hybrids with the characteristics of human peripheral blood T-lymphocytes. Immunol Lett (1983) 0.78
Androgen receptor in the human thymus. Immunol Lett (1984) 0.78
The anti-inflammatory profile of dapsone in animal models of inflammation. Agents Actions (1978) 0.77
Responses of human B-cells to recombinant lymphokines. Dev Biol Stand (1988) 0.77
Monoclonal antibody technology for mycotoxins. Biotechnol Adv (1989) 0.77
The immortalization of human lymphocytes by spheroplast fusion. Dev Biol Stand (1985) 0.77
Cardiac troponin-I: a biochemical marker for cardiac cell necrosis. Dis Markers (1993) 0.77
Proceedings: An investigation into the immunosuppressive properties of oestrogen. J Endocrinol (1976) 0.76
Detection of ochratoxin A in porcine kidneys by a monoclonal antibody-based radioimmunoassay. Appl Environ Microbiol (1987) 0.76
Determination of ochratoxin A by monoclonal antibody-based enzyme immunoassay. J Assoc Off Anal Chem (1989) 0.76
The subunits of chemically treated proteoglycan isolated from bovine nasal cartilage. Biochem J (1971) 0.75
Studies on the anti-inflammatory properties of dapsone in a variety of animal models [proceedings]. Br J Pharmacol (1977) 0.75
Human T-cell hybrids with HLA-restricted proliferative response to Epstein-Barr virus-infected B cells. Immunology (1984) 0.75
Production and characterization of monoclonal antibodies with diagnostic potential against Shigella flexneri. J Clin Lab Immunol (1989) 0.75
Pregnancy-associated alpha 2-macroglobulin - a new serum protein elevated in normal human pregnancy. J Reprod Immunol (1983) 0.75
An investigation into the immunogenicity of a GnRH analogue in male rats: a comparison of the toxicity of various adjuvants used in conjunction with GnRH-glycys. Vaccine (1996) 0.75
Catalytic antibodies: designed and accidental. Biochem Soc Trans (1993) 0.75
Catalytic antibodies: a new window on protein chemistry. Ciba Found Symp (1991) 0.75
The evolution of immunoassay technology. Parasitology (1998) 0.75
A new human trophoblast antigen isolated from immune complexes derived from placental blood and membranes. J Clin Lab Immunol (1987) 0.75
Characterization of monoclonal antibodies with specificity for the core oligosaccharide of Shigella lipopolysaccharide. Hybridoma (2001) 0.75
Development of a hormone neutralizing vaccine, using GnRH-glycys-PPD, for use in the treatment of oestrogen-dependent disorders. Ther Immunol (1995) 0.75
The maternal immune response to a new human trophoblast antigen. J Clin Lab Immunol (1988) 0.75
Molecular recognition in antibodies and its application. Experientia (1991) 0.75
Immunoscintigraphy of human ovarian cancer xenografts using a radiolabelled monoclonal antibody to human pregnancy serum-derived immune complexes. Nucl Med Commun (1988) 0.75
Proceedings: Evidence for immunoregulation by a new thymic hormone during pregnancy. J Endocrinol (1976) 0.75
Immunoneutralisation of GnRH-I, without cross-reactivity to GnRH-II, in the development of a highly specific anti-fertility vaccine for clinical and veterinary use. J Reprod Immunol (2001) 0.75
Aflatoxin monoclonals: academic development to commercial production. Lett Appl Microbiol (1990) 0.75
Exercise induced modulation of immune parameters. Biochem Soc Trans (1995) 0.75
The importance of statistical evaluation and experimental design in the interpretation of data from cancer microdetector studies. Eur J Cancer (1980) 0.75
Complex nature of the human antisperm antibody response in SCID mice. Andrologia (2004) 0.75
Anti-gonadotropin releasing hormone vaccines and their potential use in the treatment of hormone-responsive cancers. BioDrugs (1999) 0.75
The synthesis of low-molecular weight proteoglycans in rabbit-ear cartilage. FEBS Lett (1972) 0.75
Pregnancy-associated beta 1-macroglobulin (beta 1-PAM): a new serum protein associated with pregnancy serum-derived immune complexes and ovarian cancer. J Clin Lab Immunol (1981) 0.75
Proceedings: Quantitation of a new serum alpha-macroglobulin in malignant disease, steroid treatment, pregnancy and normal subjects. J Endocrinol (1974) 0.75
Pregnancy-associated alpha 2-glycoprotein. Lancet (1977) 0.75
An assay for antigen-antibody complexes in human sera using C1q-enzyme conjugates. J Clin Lab Immunol (1981) 0.75
Radiolabelled monoclonal antibodies (McAb): an alternate approach to the conventional methods for the assessment of cardiomyocyte damage in an experimental brain-death pig model. Arch Pharm Res (1998) 0.75
The distribution of pregnancy-associated prostaglandin synthetase inhibitor in the human placenta. J Pathol (1989) 0.75
Production and characterisation of anti-cardiac troponin-I monoclonal antibodies. Dis Markers (1995) 0.75
Construction of a single-chain Fv from an antibody which catalyses a Diels Alder cycloaddition. Biochem Soc Trans (1996) 0.75
The therapeutic effects of dietary fatty acid supplementation in the autoimmune disease of the MRL-mp-lpr/lpr mouse. Int J Immunopharmacol (1988) 0.75
The value of sequential marker estimations following mastectomy for breast cancer. Eur J Cancer (1980) 0.75
A comparison of circulating immune complexes, pregnancy associated beta 1-macroglobulin and galactosyltransferase as tumour markers for ovarian cancer. Aust N Z J Obstet Gynaecol (1986) 0.75
Letter: Pregnancy-associated alpha2-glycoprotein and cancer. Lancet (1976) 0.75
Ability of alpha (but not beta) form interleukin-1 to support DNA synthesis in human tonsillar B cells. Int Arch Allergy Appl Immunol (1989) 0.75